To See The Effect of Bhunimbadi Churna And Nyagrodhadi Churna In The Management Of Madhumeha (Type-2 Diabetes Mellitus)

Evaluate The Efficacy Of Bhunimbadi Churna And Nyagrodhadi Churna With Holistic Approach Of Ayurveda In The Management Of Madhumeha (Type-2 Diabetes Mellitus)

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038915

Enrollment

Registered

2021-12-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either gender in the age group of 25-65 years 2. Patients with classical signs and symptoms of Madhumeha (Avarn-janya prameha) 3. Inclusion criteria based on blood Investigations Fasting blood sugar (FBS) >126 mg/dl up to 300 mg/dl, and Patients with random blood sugar level (RBS) >200 up to 450mg/dl, or Postprandial blood sugar (PPBS) >200 mg/dl up to450 mg/dl, and Glycosylated haemoglobin > 6.5%-16% NOTE: In the above given criteria there is one should be present and HbA1c Must be > 6.5%. Newly /early diagnosed cases to be included as per following criteria: Patients who are not taking any conventional medicine for more than two months, whose sugar levels are raised and fall. within the inclusion criteria mentioned above and are willing to take Ayurvedic treatment Patient accidently diagnosed in routine check-up or when appeared with other complaints in the hospital. Early diagnosed diabetic patients (less than 2 year of diabetic history) and not taking any pharmacological drugs since last two months.

Exclusion criteria

Exclusion criteria: 1. Patients with acute/chronic liver disease with elevated liver enzymes. 2. Patients with history of alcohol abuse. 3. Patients having insulin dependent DM (type 1) and receiving insulin 4. Chronic complications like microvascular and macrovascular derangements. 5. Hyper or hypothyroidism 6. Patients reporting to be hypersensitive to any of the proposed trial drugs. 7. Pregnant women/ lactating mothers 8. Participation in other clinical studies in past 12 weeks. 9. Takes psychotropic medications that raise blood glucose (e.g. atypical antipsychotics) 10. Patients Fails to Fall in Inclusion criteria of Blood sugar level.

Design outcomes

Primary

Measure	Time frame
1.Reduction in HBA1C level 2.Improvement in Signs and Symptoms of Madhumeha Timepoint: 90-120 Days	—

Secondary

Measure	Time frame
1.Reduction in Blood sugar fasting, post prandial, random (in mg/dl) 2.Improvement in Quality of Life in DMT2 Patients Timepoint: 90-120 Days	—

Countries

India

Contacts

Public ContactDr Raja Ram Mahto

All India Institute Of Ayurveda

mahtorajaram@yahoo.com8877033663

Outcome results